Stem is trading at $4.52, up 6.35% from its October 5 close of $4.25, with no clear company-specific catalyst identified for the October 6 pre-market move. - The broader market is modestly higher, but supplied index gains below 0.5% do not explain Stem’s larger move. - The latest identified analyst action was a UBS upgrade reported September 25, not a new overnight development. - Stem’s next earnings report is expected later in October.